The risk of death for each NB patient is defined based on disease presentation, age at diagnosis, tumor histology, tumor ploidy, localized or metastatic disease, recurrent segmental chromosome copy number alterations, and amplification of the proto-oncogene MYCN [7,10]. This evidence concerns the gene MYCN and neoplasm.